Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030
Heather A. Parsons, Timothy Blewett, Xun Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong, Vandana G. Abramson, Ayan R. Patel, Justin Cheng, Adam Brufsky, Justin Rhoades, Jeremy Force, Rong Liu, Tiffany A. Traina, Lisa A. Carey, Mothaffar F. Rimawi, Kathy D. Miller, Vered Stearns, Jennifer M. Specht, Carla I. Falkson, Harold J. Burstein, Antonio C. Wolff, Eric P. Winer, Nabihah Tayob, Ian E. Krop, G. Mike Makrigiorgos, Todd R. Golub, Erica L. Mayer, Viktor A. Adalsteinsson
Topics & Concepts
MedicineBreast cancerTriple-negative breast cancerChemotherapyOncologyInternal medicineCancerCirculating tumor DNANeoadjuvant therapyCancer Genomics and DiagnosticsBreast Cancer Treatment StudiesCancer Cells and Metastasis